Summary Background The Fragmin and Fast Revascularisation during Instability in
Coronary artery disease II trial (FRISC II) compared an early invasive with an early non …

OBJECTIVE To assess the safety and feasibility of acute transport followed by rescue
percutaneous transluminal coronary angioplasty (PTCA) or primary PTCA in patients with …

DING proteins, identified mainly by their eponymous N-terminal sequences, are ubiquitous
in living organisms. Amongst bacteria, they are common in pseudomonads, and have been …

Background. We have known that patients with renal insufficiency (creatinine level) have
increased mortality for coronary artery disease. In this study, the relationship between …

The inhibitors of the platelet membrane glycoprotein IIb/IIIa show considerable promise as
antiplatelet agents. These drugs are easily titrated when administered intravenously and are …

A synovial stimulating protein (SSP) has previously been isolated from rheumatoid arthritis
synovial fluid and from the culture fluid of rheumatoid arthritis synovial fibroblasts. We have …

Coagulation factor Xa is the sole enzyme responsible for activating the zymogen
prothrombin to thrombin, resulting in fibrin generation, platelet activation, and subsequent …

Abstract PD-198961, 3-(4-5-[(2R, 6S)-2, 6-dimethyltetrahydro-1 (2H)-pyridinyl] pentyl-3-oxo-
3, 4-dihydro-2-quinoxalinyl)-4-hydroxybenzenecarboximidamide, is a novel, synthetic factor …

Heparin-induced thrombocytopenia (HIT) is an immune-mediated adverse drug reaction that
is associated with thrombotic events of the venous and arterial circulatory systems stemming …

Glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: Pathophysiologic foundation and
clinical findings - ScienceDirect Skip to main contentSkip to article Elsevier logo Journals & …